RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+12.27%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$913M
AUM Growth
+$913M
(+18%)
Cap. Flow
+$64M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
62.19%
Holding
60
New
12
Increased
4
Reduced
12
Closed
4
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$58.3M |
| 2 |
Arbutus Biopharma
ABUS
|
$47.4M |
| 3 |
Ascendis Pharma
ASND
|
$17.8M |
| 4 |
Omeros
OMER
|
$16.5M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$14.9M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$36.9M |
| 2 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$20.2M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
$19.5M |
| 4 |
Novavax
NVAX
|
$15M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$13.9M |
Sector Composition
| 1 | Healthcare | 77.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
1
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $80.9M | 8.04% | 8,207,530 +1,507,530 | +23% | +$14.9M |
|
|
DYAX
2
DELISTED
DYAX CORPORATION
DYAX
| $70.5M | 7% | 4,207,594 -738,103 | -15% | -$12.4M |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $62.5M | 6.21% | 6,926,617 -123,739 | -2% | -$1.12M |
|
|
RGLS
4
DELISTED
Regulus Therapeutics
RGLS
| $60.8M | 6.04% | 3,590,688 -1,152,223 | -24% | -$19.5M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $58.4M | 5.8% | 2,428,571 | – | – |
|
|
6
Dynavax Technologies
DVAX
$1.19B
| $58.3M | 5.79% | +2,600,000 | New | +$58.3M |
|
7
TG Therapeutics
TGTX
$4.65B
| $48.4M | 4.8% | 3,125,149 -225,300 | -7% | -$3.49M |
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $47.6M | 4.72% | 1,555,355 | – | – |
|
|
9
Arbutus Biopharma
ABUS
$711M
| $47.4M | 4.71% | +2,714,800 | New | +$47.4M |
|
10
Xencor
XNCR
$580M
| $32.9M | 3.27% | 2,149,423 +750,000 | +54% | +$11.5M |
|
11
Larimar Therapeutics
LRMR
$310M
| $29M | 2.88% | 732,960 | – | – |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $24.2M | 2.4% | 200,379 -305,743 | -60% | -$36.9M |
|
|
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $23.8M | 2.36% | 1,026,402 | – | – |
|
|
ZSPH
14
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $23.8M | 2.36% | 564,483 | – | – |
|
15
Sangamo Therapeutics
SGMO
$157M
| $19.1M | 1.9% | 1,220,209 | – | – |
|
|
16
Ascendis Pharma
ASND
$11.8B
| $17.8M | 1.76% | +1,023,652 | New | +$17.8M |
|
|
JUNO
17
DELISTED
Juno Therapeutics, Inc.
JUNO
| $17M | 1.69% | 280,000 | – | – |
|
|
18
Omeros
OMER
$283M
| $16.5M | 1.64% | +749,000 | New | +$16.5M |
|
19
Protara Therapeutics
TARA
$120M
| $14.5M | 1.44% | 1,250,000 | – | – |
|
|
AGRX
20
DELISTED
Agile Therapeutics, Inc
AGRX
| $13.5M | 1.34% | +1,458,792 | New | +$13.5M |
|
|
21
Novavax
NVAX
$1.21B
| $11.8M | 1.18% | 1,431,232 -1,809,851 | -56% | -$15M |
|
22
TherapeuticsMD
TXMD
$12.8M
| $10.2M | 1.01% | 1,680,395 -1,530,737 | -48% | -$9.26M |
|
|
ARRY
23
DELISTED
Array Biopharma Inc
ARRY
| $10M | 0.99% | +1,357,584 | New | +$10M |
|
|
CNCE
24
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $10M | 0.99% | +660,000 | New | +$10M |
|
|
OREX
25
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $9.29M | 0.92% | +1,186,229 | New | +$9.29M |
|